IgG

IgG

IgG Informations sur la molécule

Molecule Name
Immunoglobulin G
Alias de la molécule
IgG
Drug Development Progress
Nombre de médicaments cliniques8
Nombre de médicaments commercialisés1
Phase de R&D la plus avancéeApproved
Alias de la cible
Immunoglobulin G
Contexte de la molécule
The Anti-Human IgG-Acridine Ester is an acridinium ester labeled Monoclonal mouse anti-human IgG antibody can be used to capture the human IgG in Chemiluminescence procedures. The antibody reacts with the Fc portion of human IgG heavy chain but not with the Fab portion of human IgG. No antibody was detected against human IgM or IgA, or against non-immunoglobulin serum proteins. The antibody has been tested by ELISA and/or solid-phase adsorbed to ensure minimal cross-reaction with mouse, cynomolgus and bovine serum proteins, but it is not sure if the product cross-react with immunoglobulins from other species. Acridinium ester is one of the most commonly used excited substrates for protein labeling and widely used in automated instruments because of its high sensitivity with detection limits in the attomole range. Acridinium ester can be triggering by chemiluminescent substrate solution and generate intense signal, the result signals (relative light units, RLU) can be measured at 430 nm. The Anti-human IgG-Acridine Ester is easy to capture the human IgG, and the bounded human IgG have no activity lost, this ready to use products could greatly save your protein labeling time and hassle, and help us get the best performance and highly reproducible results.

IgG Liste de produits

Host Species
  • Mouse(8)
Conjugate
  • PE Labeled(2)
  • Acridinium ester Labeled(1)
  • APC Labeled(1)
  • Biotin-labeled(1)
  • Europium chelate Labeled(1)
  • FA Labeled(1)
  • HRP Labeled(1)
Reactive Species
  • -(2)
  • Human(2)
  • Human IgG Fc, including IgG1–IgG4 isotypes and Fc-engineered variants (e.g. N297A, LALA, YTE, LS, S239D/I332E)(2)
  • Human IgG(1)
  • Human IgG Fc (IgG1, IgG2, IgG3, IgG4)(1)
Applications
  • ELISA(2)
  • Flow(1)
  • MPCLIA(1)
  • WB(1)
MoleculeCat. No.Product NameHost SpeciesReactive SpeciesApplicationsSize&PriceAdd to Cart
IgG
Monoclonal Anti-Human IgG Antibody FA-Labeled (for TR-FRET)
Mouse
-
TR-FRET

$191.00

1000tests
IgG
Monoclonal Anti-Human IgG Antibody Europium chelate (for TR-FRET)
Mouse
-
TR-FRET

$191.00

1000tests
IgG
HRP conjugated Anti-Human-IgG-Fc Antibody (6F11C8), mAb
Mouse
Human
ELISA

$360.00

100ug
IgG
PE-Labeled Mouse-Anti-Human-IgG Antibody, Mouse IgG1 (6F11C8)
Mouse
Human IgG
Flow

$85.00

25tests
IgG
Anti-Human IgG Antibody-Acridinium ester
Mouse
Human
MPCLIA

$40.00

100ug
IgG
APC conjugated Monoclonal Anti-Human IgG Antibody, Mouse IgG1 (6F11C8)
Mouse
Human IgG Fc, including IgG1–IgG4 isotypes and Fc-engineered variants (e.g. N297A, LALA, YTE, LS, S239D/I332E)
Flow

$135.00

25tests
IgG
Biotinylated Monoclonal Mouse Anti-Human-IgG Antibody, Mouse IgG1 (6F11C8)
Mouse
Human IgG Fc (IgG1, IgG2, IgG3, IgG4)
ELISA

$110.00

25ug
IgG
PE conjugated Monoclonal Anti-Human IgG Antibody, Mouse IgG1 (6F11C8)
Mouse
Human IgG Fc, including IgG1–IgG4 isotypes and Fc-engineered variants (e.g. N297A, LALA, YTE, LS, S239D/I332E)
Flow

$135.00

25tests
You Have Viewed 1-8 Of 8 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
RicefidaseKJ-103; KJ103Phase 3 ClinicalShanghai Bao Pharmaceuticals Co Ltd
Anti-Glomerular Basement Membrane Disease; Guillain-Barre Syndrome; Rejection of renal transplantation
Details
AT-02AT-02Phase 2 ClinicalAttralus Inc
Amyloidosis; Immunoglobulin Light-chain Amyloidosis
Details
JZB-34AAFP; JZB-34Phase 1 ClinicalShanghai Kexin Biotech Co Ltd
Hypersensitivity
Details
Emicizumab biosimilar (Jushi Biopharmaceutical)SYS6053; SYS-6053Phase 1 ClinicalJushi Biopharmaceutical Co Ltd
Hemophilia A; Hemorrhage
Details
S-1117S-1117Phase 1 ClinicalSeismic Therapeutics Inc
Immune System Diseases
Details
BHV-1300BHV-1300Phase 1 ClinicalBiohaven Pharmaceuticals Inc
Arthritis, Rheumatoid; Graves Disease
Details
HNSA-5487HNSA 5487; HNSA-5487Phase 1 ClinicalHansa Biopharma Ab
Autoimmune Diseases; Neoplasms
Details
Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD)Phase 1 ClinicalUniversity Of California San Diego
Leukemia, Myeloid, Acute
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
ImlifidaseMac-1ApprovedHansamed IncIdefirixEURejection of renal transplantationHansa Biopharma Ab2020-08-25
Guillain-Barre Syndrome; Kidney Diseases; Kidney Failure, Chronic; Purpura, Thrombotic Thrombocytopenic; Rejection of renal transplantation; Rejection of organ transplantation; Renal Insufficiency, Chronic
Details
Customer Reviews